Cassava sciences to hold corporate update on november 25th

Austin, texas, nov. 24, 2024 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on developing a novel treatment for alzheimer's disease, today announced it will hold a conference call and webcast on monday, november 25th at 8:00 a.m. eastern time.
SAVA Ratings Summary
SAVA Quant Ranking